An excimer lamp used for light therapy emits ultraviolet rays of 308 nm wavelength from a xenon chlorine gas, and is effective in psoriasis vulgaris, pustulosis palmaris et plantaris and vitiligo vulgaris. In our institution, we treat various diseases with VTRAC (Photo MedexTM, America), which is a target type excimer lamp. We have examined the hair regrowth effect in 13 patients with alopecia treated with the target type excimer lamp once or twice a week, comprising 6 cases of solitary alopecia areata, 3 cases of alopecia areata multiplex and 4 cases of alopecia universalis. We determined the effect by three criteria, as reported by Zakaria et al. First, the number of treatments required to see hair regrowth ; second, judgment of the degree of hair regrowth on a 6-point scale (0 = no hair regrowth, 1 = 1%-24% hair regrowth, 2 = 25%-49% hair regrowth, 3 = 50%-74% hair regrowth, 4 = 75%-99% hair regrowth, and 5 = complete hair regrowth) ; and third, evaluation of patients. In 5 of 6 patients with solitary alopecia areata more than 75% hair regrowth was achieved, and 3 patients achieved complete response. Furthermore, even in the case that was refractory to conventional treatment, hair regrowth was recognized after 3-8 irradiation treatments. One patient with alopecia areata multiplex was cured after 18 irradiation treatments over a period of 4 months. Although regrowth of downy hair was seen in patients with alopecia universalis, they didn't show enough response. Compared with PUVA therapy, described in the treatment guidelines for alopecia areata in 2010, a target type excimer lamp emits radiation only in the lesion area, and thus avoids unnecessary irradiation. In conclusion, a target type excimer lamp can be a new standard therapeutic option in alopecia areata.
View full abstract